Tagworks Pharmaceuticals BV logo

Tagworks Pharmaceuticals BV

Tagworks Pharmaceuticals is developing a pipeline of Radioimmunotherapy and Antibody-Drug Conjugate product candidates. Also, it offers preclinical companion imaging services using its proprietary in vivo Chemistry platform.

Tagworks Pharmaceuticals a spin-out of Royal Philips Electronics and is applying bioorthogonal conjugation and elimination chemistry in living systems to improve the efficacy of cancer therapies and to enable approaches in companion diagnostics.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.tagworkspharma.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
c/o Radboud University Medical CenterDepartment of Nuclear Medicine and Radiology (route 766) P.O. Box 91016500 HB
Nijmegen
Netherlands
Email
Contact Number
+31 6 25 02 15 25

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/tagworks-pharmaceuticals” connections=”true” suffix=””]

Tagworks technology enables the actuation of tagged antibodies through selective chemical manipulation in vivo, improving the efficacy of the approach Radioimmuno-imaging and therapy and Antibody-Drug Conjugates (ADCs).

Tagworks R&D activities are supported through several grants, provided by the European Union, the USA National Institutes of Health and the USA Department of Defense.